Ophthalmological Adverse Events of Tralokinumab in AD
Condition:   Atopic Dermatitis Intervention:   Sponsors:   Nantes University Hospital;   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: LEO 158968;   Drug: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Ophthalmological Adverse Events of Tralokinumab in AD
Condition:   Atopic Dermatitis Intervention:   Sponsors:   Nantes University Hospital;   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials

Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: LEO 158968;   Drug: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials